These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 3501940

  • 1. In vitro activities of aztreonam, imipenem, and amoxycillin-clavulanate against ampicillin-resistant Haemophilus influenzae.
    Powell M, Williams JD.
    Antimicrob Agents Chemother; 1987 Dec; 31(12):1871-3. PubMed ID: 3501940
    [Abstract] [Full Text] [Related]

  • 2. Reevaluation of interpretive criteria for Haemophilus influenzae by using meropenem (10-microgram), imipenem (10-microgram), and ampicillin (2- and 10-microgram) disks.
    Zerva L, Biedenbach DJ, Jones RN.
    J Clin Microbiol; 1996 Aug; 34(8):1970-4. PubMed ID: 8818892
    [Abstract] [Full Text] [Related]

  • 3. In-vitro activity of imipenem against 100 strains of serotype b and nontypable Haemophilus influenzae, including strains resistant to ampicillin, chloramphenicol or both.
    Campos JM, Gill CJ, Ahonkhai VI.
    J Antimicrob Chemother; 1985 Nov; 16(5):549-54. PubMed ID: 3878361
    [Abstract] [Full Text] [Related]

  • 4. In-vitro susceptibility of Haemophilus influenzae to meropenem compared with imipenem, five other beta-lactams, chloramphenicol and ciprofloxacin.
    Powell M, Seetulsingh P, Williams JD.
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():175-81. PubMed ID: 2808206
    [Abstract] [Full Text] [Related]

  • 5. Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of beta-lactamase-positive strains resistant to amoxicillin-clavulanate: results of a national multicenter surveillance study.
    Doern GV, Brueggemann AB, Pierce G, Holley HP, Rauch A.
    Antimicrob Agents Chemother; 1997 Feb; 41(2):292-7. PubMed ID: 9021182
    [Abstract] [Full Text] [Related]

  • 6. Antimicrobial activities of piperacillin-tazobactam against Haemophilus influenzae isolates, including beta-lactamase-negative ampicillin-resistant and beta-lactamase-positive amoxicillin-clavulanate-resistant isolates, and mutations in their quinolone resistance-determining regions.
    Hirakata Y, Ohmori K, Mikuriya M, Saika T, Matsuzaki K, Hasegawa M, Hatta M, Yamamoto N, Kunishima H, Yano H, Kitagawa M, Arai K, Kawakami K, Kobayashi I, Jones RN, Kohno S, Yamaguchi K, Kaku M.
    Antimicrob Agents Chemother; 2009 Oct; 53(10):4225-30. PubMed ID: 19651910
    [Abstract] [Full Text] [Related]

  • 7. Comparative in vitro activity of imipenem against Haemophilus influenzae and Haemophilus parainfluenzae.
    Cerami AT, Shungu DL.
    Antimicrob Agents Chemother; 1986 Jul; 30(1):179-80. PubMed ID: 3489437
    [Abstract] [Full Text] [Related]

  • 8. Activity of a new carbapenem antibiotic, meropenem, against Haemophilus influenzae strains with beta-lactamase- and non-enzyme-mediated resistance to ampicillin.
    Jorgensen JH, Maher LA, Howell AW.
    Antimicrob Agents Chemother; 1991 Mar; 35(3):600-2. PubMed ID: 2039214
    [Abstract] [Full Text] [Related]

  • 9. In vitro susceptibilities of 180 clinical isolates of Haemophilus influenzae to ampicillin, amoxycillin/clavulanate, cefaclor, cefuroxime, cefotaxime, clarithromycin, and azithromycin.
    Delmée M, Carpentier M, Glupczynski Y, Gordts B, Magerman K, Simon A, Surmont I, Van de Vyvere M, Van Landuyt H, Van Nimmen L, Van Noyen R.
    Acta Clin Belg; 1996 Mar; 51(4):237-43. PubMed ID: 8858889
    [Abstract] [Full Text] [Related]

  • 10. Interpretive criteria for susceptibilities of Haemophilus influenzae to ampicillin, amoxicillin, and amoxicillin-clavulanic acid.
    Fuchs PC, Barry AL.
    J Clin Microbiol; 1994 Nov; 32(11):2846-50. PubMed ID: 7852584
    [Abstract] [Full Text] [Related]

  • 11. Susceptibilities of beta-lactamase-producing and -nonproducing ampicillin-resistant strains of Haemophilus influenzae to ceftibuten, cefaclor, cefuroxime, cefixime, cefotaxime, and amoxicillin-clavulanic acid.
    Barry AL, Fuchs PC, Pfaller MA.
    Antimicrob Agents Chemother; 1993 Jan; 37(1):14-8. PubMed ID: 8431012
    [Abstract] [Full Text] [Related]

  • 12. Beta-lactamase production and susceptibilities to amoxicillin, amoxicillin-clavulanate, ticarcillin, ticarcillin-clavulanate, cefoxitin, imipenem, and metronidazole of 320 non-Bacteroides fragilis Bacteroides isolates and 129 fusobacteria from 28 U.S. centers.
    Appelbaum PC, Spangler SK, Jacobs MR.
    Antimicrob Agents Chemother; 1990 Aug; 34(8):1546-50. PubMed ID: 2221864
    [Abstract] [Full Text] [Related]

  • 13. Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella (Branhamella) catarrhalis isolated in the UK from sputa.
    Powell M, McVey D, Kassim MH, Chen HY, Williams JD.
    J Antimicrob Chemother; 1991 Aug; 28(2):249-59. PubMed ID: 1778856
    [Abstract] [Full Text] [Related]

  • 14. [Comparison of the in vitro activity of amoxycillin + clavulanic acid and ampicillin + sulbactam combinations against 50 Haemophilus influenzae strains producing beta lactamase].
    Moittie D, Simonet M, Veron M.
    Pathol Biol (Paris); 1989 May; 37(5):390-3. PubMed ID: 2789362
    [Abstract] [Full Text] [Related]

  • 15. Failure to detect ampicillin-resistant, non-beta-lactamase-producing Haemophilus influenzae by standard disk susceptibility testing.
    Mendelman PM, Chaffin DO, Clausen C, Stull TL, Needham C, Williams JD, Smith AL.
    Antimicrob Agents Chemother; 1986 Aug; 30(2):274-80. PubMed ID: 3490217
    [Abstract] [Full Text] [Related]

  • 16. Susceptibility of multiply resistant Haemophilus influenzae to newer antimicrobial agents.
    Jorgensen JH, Doern GV, Thornsberry C, Preston DA, Redding JS, Maher LA, Tubert T.
    Diagn Microbiol Infect Dis; 1988 Jan; 9(1):27-32. PubMed ID: 3259490
    [Abstract] [Full Text] [Related]

  • 17. Activities of newer beta-lactam antibiotics against ampicillin, chloramphenicol, or multiply-resistant Haemophilus influenzae.
    Strandberg DA, Jorgensen JH, Drutz DJ.
    Diagn Microbiol Infect Dis; 1984 Sep; 2(4):333-7. PubMed ID: 6333316
    [Abstract] [Full Text] [Related]

  • 18. Beta-lactamase production, beta-lactam sensitivity and resistance to synergy with clavulanate of 737 Bacteroides fragilis group organisms from thirty-three US centres.
    Jacobs MR, Spangler SK, Appelbaum PC.
    J Antimicrob Chemother; 1990 Sep; 26(3):361-70. PubMed ID: 2228827
    [Abstract] [Full Text] [Related]

  • 19. Isolates of β-lactamase-negative ampicillin-resistant Haemophilus influenzae causing invasive infections in Spain remain susceptible to cefotaxime and imipenem.
    García-Cobos S, Arroyo M, Pérez-Vázquez M, Aracil B, Lara N, Oteo J, Cercenado E, Campos J.
    J Antimicrob Chemother; 2014 Jan; 69(1):111-6. PubMed ID: 23943391
    [Abstract] [Full Text] [Related]

  • 20. In vitro and in vivo activities of meropenem and comparable antimicrobial agents against Haemophilus influenzae, including beta-lactamase-negative ampicillin-resistant strains.
    Miyazaki S, Fujikawa T, Kanazawa K, Yamaguchi K.
    J Antimicrob Chemother; 2001 Nov; 48(5):723-6. PubMed ID: 11679563
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.